Clinical Trials Logo

Morphine Adverse Reaction clinical trials

View clinical trials related to Morphine Adverse Reaction.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT01844206 Terminated - Pain Clinical Trials

Two Dose Epidural Morphine for Post-cesarean Analgesia

Start date: June 2013
Phase: Phase 4
Study type: Interventional

The investigators aim to assess the analgesic effect of a two-dose epidural morphine regimen for 2nd day post-cesarean pain, as part of a multimodal analgesia regimen, which includes scheduled Nonsteroidal anti-inflammatory drugs (NSAIDs). The investigators hypothesize that administration of a second dose of epidural morphine 3 mg, 24 hours after an initial intraoperative dose, will provide superior post-cesarean analgesia during the 2nd 24 hours after surgery, compared to a single epidural morphine dose regimen. The primary outcome will be the amount of intravenous morphine patients self-administer during the 2nd 24 hours post-surgery.